Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CHFS

Nuwellis (CHFS) Stock Price, News & Analysis

Nuwellis logo

About Nuwellis Stock (NASDAQ:CHFS)

Advanced Chart

Key Stats

Today's Range
$7.21
$7.59
50-Day Range
$3.53
$6.02
52-Week Range
$4.86
$37.50
Volume
31,664 shs
Average Volume
467,323 shs
Market Capitalization
$44.95 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CHFS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nuwellis and its competitors with MarketBeat's FREE daily newsletter.

CHFS Stock News Headlines

Nuwellis Appoints John L. Erb as CEO
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
See More Headlines

CHFS Stock Analysis - Frequently Asked Questions

Nuwellis, Inc. (NASDAQ:CHFS) posted its earnings results on Monday, March, 1st. The company reported ($1.57) earnings per share for the quarter, beating analysts' consensus estimates of ($1.91) by $0.34. The business earned $2.04 million during the quarter. Nuwellis had a negative trailing twelve-month return on equity of 173.61% and a negative net margin of 254.26%.

Nuwellis's stock reverse split on the morning of Friday, October 13th 2017.The 1-20 reverse split was announced on Thursday, October 12th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, October 12th 2017. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Nuwellis investors own include Tonix Pharmaceuticals (TNXP), T2 Biosystems (TTOO), Biocept (BIOC), VBI Vaccines (VBIV), Prima BioMed (IMMP), NightHawk Biosciences (NHWK) and Sorrento Therapeutics (SRNE).

Company Calendar

Last Earnings
3/01/2021
Today
7/11/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Electromedical Equipment
Sub-Industry
N/A
Current Symbol
NASDAQ:CHFS
Previous Symbol
NASDAQ:SSH
CIK
1506492
Fax
N/A
Employees
66
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($279.28)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$18.11 million
Net Margins
-254.26%
Pretax Margin
N/A
Return on Equity
-173.61%
Return on Assets
-131.01%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.87
Quick Ratio
5.97

Sales & Book Value

Annual Sales
$5.51 million
Price / Sales
8.16
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$12.79 per share
Price / Book
0.58

Miscellaneous

Outstanding Shares
6,037,000
Free Float
N/A
Market Cap
$44.95 million
Optionable
Not Optionable
Beta
1.55
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:CHFS) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners